Profilo
Bob Deresiewicz is currently a Director at Asher Biotherapeutics, Inc. Previously, he was a Senior Managing Director and Partner at Wellington Management Co. LLP (Private Equity) from 2000 to 2022.
He obtained an undergraduate degree from The Trustees of Columbia University in The City of New York, a doctorate from Icahn School of Medicine at Mount Sinai, and an MBA from Harvard Business School.
Posizioni attive di Bob Deresiewicz
| Società | Posizione | Inizio |
|---|---|---|
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies | Direttore/Membro del Consiglio | 06/07/2022 |
Precedenti posizioni note di Bob Deresiewicz
| Società | Posizione | Fine |
|---|---|---|
Wellington Management Co. LLP (Private Equity)
Wellington Management Co. LLP (Private Equity) Investment ManagersFinance Wellington Management invests in companies located in the US. The firm targets companies in sectors such as consumer, technology, healthcare, financial services, climate technology and biotechnology. It provides financing for later stage capital requirements. | Investitore di Private Equity | 30/06/2022 |
Formazione di Bob Deresiewicz
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Società collegate
| Aziende private | 5 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wellington Management Co. LLP (Private Equity)
Wellington Management Co. LLP (Private Equity) Investment ManagersFinance Wellington Management invests in companies located in the US. The firm targets companies in sectors such as consumer, technology, healthcare, financial services, climate technology and biotechnology. It provides financing for later stage capital requirements. | Finance |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies | Health Technology |
















